DE69534100D1 - Diagnose und behandlung von zellproliferativen erkrankungen mit beteiligung von klonalen makrophagen - Google Patents
Diagnose und behandlung von zellproliferativen erkrankungen mit beteiligung von klonalen makrophagenInfo
- Publication number
- DE69534100D1 DE69534100D1 DE69534100T DE69534100T DE69534100D1 DE 69534100 D1 DE69534100 D1 DE 69534100D1 DE 69534100 T DE69534100 T DE 69534100T DE 69534100 T DE69534100 T DE 69534100T DE 69534100 D1 DE69534100 D1 DE 69534100D1
- Authority
- DE
- Germany
- Prior art keywords
- macrophages
- cancerous
- diagnosis
- clonal
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/5055—Cells of the immune system involving macrophages
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- AIDS & HIV (AREA)
- General Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/286,745 US5580715A (en) | 1994-08-05 | 1994-08-05 | Diagnosis of cancer having clonal macrophage involvement |
US08/473,040 US5639600A (en) | 1994-08-05 | 1995-06-06 | Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement |
US473040 | 1995-06-06 | ||
PCT/US1995/009715 WO1996004019A1 (en) | 1994-08-05 | 1995-08-01 | Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement |
US286745 | 1999-04-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69534100D1 true DE69534100D1 (de) | 2005-04-28 |
DE69534100T2 DE69534100T2 (de) | 2006-03-23 |
Family
ID=26964048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69534100T Expired - Fee Related DE69534100T2 (de) | 1994-08-05 | 1995-08-01 | Diagnose und behandlung von zellproliferativen erkrankungen mit beteiligung von klonalen makrophagen |
Country Status (8)
Country | Link |
---|---|
US (1) | US5639600A (de) |
EP (1) | EP0772456B1 (de) |
JP (1) | JPH10503656A (de) |
AT (1) | ATE291614T1 (de) |
AU (1) | AU700490B2 (de) |
CA (1) | CA2196776A1 (de) |
DE (1) | DE69534100T2 (de) |
WO (1) | WO1996004019A1 (de) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6140098A (en) * | 1996-08-30 | 2000-10-31 | Schering Corporation | Nucleic acids encoding mammalian proteinases; related reagents |
CA2268069A1 (en) * | 1996-10-04 | 1998-04-09 | Chronix Biomedical | Diagnostic detection of nucleic acids |
US7087648B1 (en) * | 1997-10-27 | 2006-08-08 | The Regents Of The University Of California | Methods for modulating macrophage proliferation using polyamine analogs |
US8198334B2 (en) * | 1997-10-27 | 2012-06-12 | Pathologica Llc | Methods for modulating macrophage proliferation in ocular disease using polyamine analogs |
CN1441677A (zh) * | 2000-03-31 | 2003-09-10 | Idec药物公司 | 抗细胞因子抗体或拮抗剂与抗-cd20在b细胞淋巴瘤治疗中的联合应用 |
DE60219627T2 (de) | 2001-06-04 | 2008-02-07 | The General Hospital Corp., Boston | Nachweis und therapie von empfindlichem plaque mit photodynamischen verbindungen |
US20030064965A1 (en) * | 2001-10-02 | 2003-04-03 | Jacob Richter | Method of delivering drugs to a tissue using drug-coated medical devices |
US20030186246A1 (en) * | 2002-03-28 | 2003-10-02 | Willey James C. | Multiplex standardized reverse transcriptase-polymerase chain reacton method for assessment of gene expression in small biological samples |
NO326130B1 (no) * | 2002-10-08 | 2008-10-06 | Enok Tjotta | Fremgangsmate for seleksjon og testing av forbindelser som inhiberer eller stimulerer klonal cellevekst |
WO2006103659A2 (en) * | 2005-03-30 | 2006-10-05 | Yeda Research And Development Co. Ltd. | Methods and systems for generating cell lineage tree of multiple cell samples |
CA2623203C (en) * | 2005-09-23 | 2014-08-12 | Pathologica, Llc | Methods for treating viral infections using polyamine analogs |
US20070202515A1 (en) * | 2005-10-12 | 2007-08-30 | Pathologica, Llc. | Promac signature application |
EP2054058B1 (de) | 2006-08-04 | 2016-11-09 | Beth Israel Deaconess Medical Center | Pyruvatkinasehemmer und verfahren zur behandlung von erkrankungen |
EP2121586B1 (de) | 2007-03-09 | 2017-03-08 | Pathologica LLC | Mgbg zur osteopontin-regelung und behandlung von multipler sklerose |
EP2310508A1 (de) * | 2008-07-02 | 2011-04-20 | Emergent Product Development Seattle, LLC | Multitarget-bindungsproteine mit tnf-?-antagonist |
US9675566B2 (en) | 2009-07-16 | 2017-06-13 | Pathologica Llc | Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing |
NZ628513A (en) | 2009-07-16 | 2016-01-29 | Pathologica Llc | Pharmaceutical for oral delivery comprising mgbg and methods of treating disease |
WO2011056561A1 (en) | 2009-10-27 | 2011-05-12 | Beth Israel Deaconess Medical Center | Methods and compositions for the generation and use of conformation-specific antibodies |
EP2563761A1 (de) | 2010-04-29 | 2013-03-06 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Aktivatoren der menschlichen pyruvatkinase |
ES2662373T3 (es) | 2011-01-19 | 2018-04-06 | Pathologica, Llc. | Formas de dosificación farmacéutica oral de liberación controlada que comprenden MGBG |
WO2012112245A1 (en) | 2011-02-14 | 2012-08-23 | Beth Israel Deaconess Medical Center, Inc. | Modulation of phosphatidylinositol-5-phosphate-4-kinase activity |
US10487114B2 (en) | 2011-04-27 | 2019-11-26 | Beth Israel Deaconess Medical Center, Inc. | Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof |
EP3831372A1 (de) | 2013-01-08 | 2021-06-09 | Pathologica LLC | Mitoguazon zur verhinderung des rückfalls oder des fortschreitens der multiplen sklerose |
WO2017044720A1 (en) | 2015-09-11 | 2017-03-16 | Navitor Pharmaceuticals, Inc. | Rapamycin analogs and uses thereof |
MX2018004674A (es) | 2015-10-23 | 2018-09-11 | Navitor Pharm Inc | Moduladores de interacción de sestrina-gator2 y sus usos. |
EP3389664A4 (de) | 2015-12-14 | 2020-01-08 | Raze Therapeutics Inc. | Koffeininhibitoren von mthfd2 und verwendungen dafür |
EP3426243B1 (de) | 2016-03-09 | 2021-05-19 | Raze Therapeutics, Inc. | 3-phosphoglycerat-dehydrogenase-inhibitoren und verwendungen davon |
US11014882B2 (en) | 2016-03-09 | 2021-05-25 | Raze Therapeutics, Inc. | 3-phosphoglycerate dehydrogenase inhibitors and uses thereof |
WO2018089499A1 (en) | 2016-11-08 | 2018-05-17 | Navitor Pharmaceuticals, Inc. | PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF |
US11091451B2 (en) | 2016-12-05 | 2021-08-17 | Raze Therapeutics, Inc. | SHMT inhibitors and uses thereof |
WO2018191146A1 (en) | 2017-04-10 | 2018-10-18 | Navitor Pharmaceuticals, Inc. | Heteroaryl rheb inhibitors and uses thereof |
AU2018258355B2 (en) | 2017-04-26 | 2024-05-30 | Navitor Pharmaceuticals, Inc. | Modulators of sestrin-gator2 interaction and uses thereof |
RU2020112854A (ru) | 2017-11-30 | 2021-12-30 | Арракис Терапьютикс, Инк. | Фотозонды, связывающие нуклеиновые кислоты, и способы их применения |
EP3759494A4 (de) * | 2018-02-27 | 2022-01-26 | The Board of Trustees of the Leland Stanford Junior University | Manipulierte immunzellen als diagnostische sonden einer krankheit |
DK3813946T3 (da) | 2018-06-15 | 2024-08-19 | Janssen Pharmaceutica Nv | Rapamycin-analoger og anvendelser deraf |
EP3870158A4 (de) | 2018-10-24 | 2022-08-10 | Navitor Pharmaceuticals, Inc. | Polymorphe verbindungen und verwendungen davon |
US11723890B2 (en) | 2019-11-01 | 2023-08-15 | Navitor Pharmaceuticals, Inc. | Methods of treatment using an mTORC1 modulator |
JP2023506410A (ja) | 2019-12-05 | 2023-02-16 | アナクリア セラピューティクス, インコーポレイテッド | ラパマイシン類似体及びその使用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4699877A (en) * | 1982-11-04 | 1987-10-13 | The Regents Of The University Of California | Methods and compositions for detecting human tumors |
US4681840A (en) * | 1984-01-18 | 1987-07-21 | The United States Of America As Represented By The Secretary Of Commerce | Deoxyribonucleic acid molecules useful as probes for detecting oncogenes incorporated into chromosomal DNA |
US4800159A (en) * | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
US5177192A (en) * | 1987-04-02 | 1993-01-05 | Centocor, Incorporated | Method for labeling antibodies with a metal ion |
US4869903A (en) * | 1987-05-29 | 1989-09-26 | Genelabs Incorporated | Method of selectively inhibiting HIV |
US4795739A (en) * | 1987-05-29 | 1989-01-03 | Gene Labs, Inc. | Method of inhibiting HIV |
US5180816A (en) * | 1988-08-24 | 1993-01-19 | Centocor | One vial method for labeling protein/linker conjugates with technetium-99M |
US5225326A (en) * | 1988-08-31 | 1993-07-06 | Research Development Foundation | One step in situ hybridization assay |
EP0567575B1 (de) * | 1991-01-14 | 1999-10-13 | New York University | Cytokin-induziertes protein, tsg-6, seine dna und verwendung |
US5445940A (en) * | 1991-08-28 | 1995-08-29 | Brigham & Women's Hospital | Methods and compositions for detecting and treating a subset of human patients having an autoimmune disease |
-
1995
- 1995-06-06 US US08/473,040 patent/US5639600A/en not_active Expired - Lifetime
- 1995-08-01 AU AU34037/95A patent/AU700490B2/en not_active Ceased
- 1995-08-01 JP JP8506701A patent/JPH10503656A/ja active Pending
- 1995-08-01 DE DE69534100T patent/DE69534100T2/de not_active Expired - Fee Related
- 1995-08-01 CA CA002196776A patent/CA2196776A1/en not_active Abandoned
- 1995-08-01 WO PCT/US1995/009715 patent/WO1996004019A1/en active IP Right Grant
- 1995-08-01 AT AT95930787T patent/ATE291614T1/de not_active IP Right Cessation
- 1995-08-01 EP EP95930787A patent/EP0772456B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH10503656A (ja) | 1998-04-07 |
ATE291614T1 (de) | 2005-04-15 |
AU3403795A (en) | 1996-03-04 |
CA2196776A1 (en) | 1996-02-15 |
EP0772456B1 (de) | 2005-03-23 |
EP0772456A1 (de) | 1997-05-14 |
AU700490B2 (en) | 1999-01-07 |
DE69534100T2 (de) | 2006-03-23 |
EP0772456A4 (de) | 1999-06-30 |
WO1996004019A1 (en) | 1996-02-15 |
US5639600A (en) | 1997-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69534100D1 (de) | Diagnose und behandlung von zellproliferativen erkrankungen mit beteiligung von klonalen makrophagen | |
CY1122817T1 (el) | Νεα αντι-il 13 αντισωματα και χρησεις αυτων | |
ATE230614T1 (de) | Krebsbehandlung mit aminophospholipide bindenden, therapeutischen konjugaten | |
RS20150135A1 (en) | TREATMENT WITH ANTI-VEGF ANTIBODIES | |
CY1119951T1 (el) | Συνθεσεις για αυξηση δραστηριοτητας τελομερασης και αγωγη λοιμωξης hiv | |
ATE435281T1 (de) | Im cadasil bezogenes gen, diagnostikums-verfahren und therapeutische verwendung | |
DE69231245D1 (de) | Veraendertes gen bei menschlichem colorektalem-krebs | |
DE69933989D1 (de) | Biomarker und targets für die diagnose, prognose und behandlung von prostat krankheiten | |
DE69520499D1 (de) | Histidine und homohistidine derivate zur verwendung als protein farnesyltransferase hemmstoffe | |
UY23910A1 (es) | Procedimiento para la preparacion de 5- derivados sustitutivos del acido micofenolico | |
ATE324119T1 (de) | Verwendung von saccharid-konjugaten | |
NO20002979L (no) | Undersøkelse av human papillomavirus-relatert sykdom | |
ATE501722T1 (de) | Therapeutische behandlung androgenrezeptorbedingter leiden | |
UY25263A1 (es) | 6-derivados sustitutivos del ácido micofenólico.- | |
CY1115407T1 (el) | Θοριο-227 για χρηση στην ακτινοθεραπεια ασθενειων των μαλακων ιστων | |
DE69631478D1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
CY1107780T1 (el) | Μεθοδος για τη θεραπεια οφθαλμικων νεοαγγειακων ασθενειων | |
DE602004020266D1 (de) | Therapeutische und diagnostische anti-hsp 70-antikörper | |
DE69911380D1 (de) | Verwendung von isatin- und oxindolderivaten zur herstellung von arzeneimittel für die behandlung von mykobakteriellen erkrankungen | |
BR0010702A (pt) | Novas quinonas como terapias de doenças | |
DE69934694D1 (de) | Bpc-1: ein ausgeschiedenes gehirnspezifisches protein das von prostata- und blasen-krebszellen exprimiert und ausgeschieden wird | |
EP1605847A4 (de) | Gegen antikörper gerichtete photodynamische therapie | |
ATE311871T1 (de) | Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten | |
BR0014372A (pt) | Derivados de 5-hidroxissapogenina com atividade antidemência | |
TR200200278T2 (tr) | Kalsilitik bileşimler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |